Vestor Capital LLC Sells 32,209 Shares of UnitedHealth Group Incorporated $UNH

Vestor Capital LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 98.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 391 shares of the healthcare conglomerate’s stock after selling 32,209 shares during the period. Vestor Capital LLC’s holdings in UnitedHealth Group were worth $159,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Nvwm LLC grew its holdings in shares of UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 33 shares during the last quarter. Wellington Altus USA Inc. raised its position in shares of UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $29,000. Compass Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $29,000. Finally, Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $440.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 17th. Piper Sandler raised their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a report on Wednesday, October 14th. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research report on Friday, October 9th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Finally, Robert W. Baird reduced their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a research report on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $463.93.

Get Our Latest Report on UNH

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $404.88 on Wednesday. The company has a market capitalization of $362.78 billion, a price-to-earnings ratio of 23.12, a P/E/G ratio of 1.44 and a beta of 0.51. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock’s fifty day simple moving average is $390.98 and its 200-day simple moving average is $364.53.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same period in the prior year, the business earned $2.59 EPS. The business’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is 53.00%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.